nodes	percent_of_prediction	percent_of_DWPC	metapath
Eplerenone—hypertension—focal segmental glomerulosclerosis	0.696	1	CtDrD
Eplerenone—CYP3A7—Cyclosporine—focal segmental glomerulosclerosis	0.0702	0.329	CbGbCtD
Eplerenone—CYP3A7-CYP3A51P—Cyclosporine—focal segmental glomerulosclerosis	0.0702	0.329	CbGbCtD
Eplerenone—CYP3A5—Cyclosporine—focal segmental glomerulosclerosis	0.0527	0.247	CbGbCtD
Eplerenone—CYP3A4—Cyclosporine—focal segmental glomerulosclerosis	0.0205	0.0961	CbGbCtD
Eplerenone—Serum triglycerides increased—Cyclosporine—focal segmental glomerulosclerosis	0.0125	0.177	CcSEcCtD
Eplerenone—NR3C2—nephron—focal segmental glomerulosclerosis	0.0055	0.398	CbGeAlD
Eplerenone—Unspecified disorder of autonomic nervous system—Cyclosporine—focal segmental glomerulosclerosis	0.00469	0.0666	CcSEcCtD
Eplerenone—Function kidney decreased—Cyclosporine—focal segmental glomerulosclerosis	0.00412	0.0585	CcSEcCtD
Eplerenone—Autonomic neuropathy—Cyclosporine—focal segmental glomerulosclerosis	0.00396	0.0563	CcSEcCtD
Eplerenone—Urine abnormality—Cyclosporine—focal segmental glomerulosclerosis	0.00162	0.0231	CcSEcCtD
Eplerenone—Hypertriglyceridaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00157	0.0222	CcSEcCtD
Eplerenone—CYP3A7-CYP3A51P—nephron tubule—focal segmental glomerulosclerosis	0.00155	0.112	CbGeAlD
Eplerenone—Urine analysis abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.00153	0.0217	CcSEcCtD
Eplerenone—Serum creatinine increased—Cyclosporine—focal segmental glomerulosclerosis	0.00146	0.0208	CcSEcCtD
Eplerenone—Blood triglycerides increased—Cyclosporine—focal segmental glomerulosclerosis	0.00137	0.0195	CcSEcCtD
Eplerenone—CYP3A7-CYP3A51P—cortex of kidney—focal segmental glomerulosclerosis	0.00133	0.0961	CbGeAlD
Eplerenone—Menstrual disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00132	0.0187	CcSEcCtD
Eplerenone—Influenza-like symptoms—Cyclosporine—focal segmental glomerulosclerosis	0.00126	0.0179	CcSEcCtD
Eplerenone—NR3C2—nephron tubule—focal segmental glomerulosclerosis	0.00119	0.086	CbGeAlD
Eplerenone—NR3C2—kidney—focal segmental glomerulosclerosis	0.00104	0.0756	CbGeAlD
Eplerenone—Breast pain—Cyclosporine—focal segmental glomerulosclerosis	0.00103	0.0146	CcSEcCtD
Eplerenone—Cardiovascular disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00102	0.0145	CcSEcCtD
Eplerenone—NR3C2—cortex of kidney—focal segmental glomerulosclerosis	0.00102	0.0736	CbGeAlD
Eplerenone—Hyperbilirubinaemia—Cyclosporine—focal segmental glomerulosclerosis	0.000989	0.014	CcSEcCtD
Eplerenone—Hyperuricaemia—Cyclosporine—focal segmental glomerulosclerosis	0.000969	0.0138	CcSEcCtD
Eplerenone—NR3C2—ACE Inhibitor Pathway—AGTR2—focal segmental glomerulosclerosis	0.000964	0.149	CbGpPWpGaD
Eplerenone—Creatinine increased—Cyclosporine—focal segmental glomerulosclerosis	0.000945	0.0134	CcSEcCtD
Eplerenone—Blood uric acid increased—Cyclosporine—focal segmental glomerulosclerosis	0.000916	0.013	CcSEcCtD
Eplerenone—Hyperkalaemia—Cyclosporine—focal segmental glomerulosclerosis	0.000883	0.0126	CcSEcCtD
Eplerenone—Influenza like illness—Cyclosporine—focal segmental glomerulosclerosis	0.000873	0.0124	CcSEcCtD
Eplerenone—Blood urea increased—Cyclosporine—focal segmental glomerulosclerosis	0.000849	0.0121	CcSEcCtD
Eplerenone—NR3C2—ACE Inhibitor Pathway—ACE—focal segmental glomerulosclerosis	0.000823	0.127	CbGpPWpGaD
Eplerenone—Gynaecomastia—Cyclosporine—focal segmental glomerulosclerosis	0.000804	0.0114	CcSEcCtD
Eplerenone—CYP11B2—ACE Inhibitor Pathway—AGTR2—focal segmental glomerulosclerosis	0.000788	0.122	CbGpPWpGaD
Eplerenone—Diabetes mellitus—Cyclosporine—focal segmental glomerulosclerosis	0.00075	0.0107	CcSEcCtD
Eplerenone—NR3C2—ACE Inhibitor Pathway—AGTR1—focal segmental glomerulosclerosis	0.000742	0.114	CbGpPWpGaD
Eplerenone—Libido decreased—Cyclosporine—focal segmental glomerulosclerosis	0.000704	0.01	CcSEcCtD
Eplerenone—Renal impairment—Cyclosporine—focal segmental glomerulosclerosis	0.000686	0.00974	CcSEcCtD
Eplerenone—CYP11B2—ACE Inhibitor Pathway—ACE—focal segmental glomerulosclerosis	0.000673	0.104	CbGpPWpGaD
Eplerenone—Disturbance in sexual arousal—Cyclosporine—focal segmental glomerulosclerosis	0.000648	0.0092	CcSEcCtD
Eplerenone—CYP3A5—nephron tubule—focal segmental glomerulosclerosis	0.000642	0.0465	CbGeAlD
Eplerenone—Blood creatinine increased—Cyclosporine—focal segmental glomerulosclerosis	0.000611	0.00869	CcSEcCtD
Eplerenone—CYP11B2—ACE Inhibitor Pathway—AGTR1—focal segmental glomerulosclerosis	0.000606	0.0935	CbGpPWpGaD
Eplerenone—CYP3A5—kidney—focal segmental glomerulosclerosis	0.000564	0.0409	CbGeAlD
Eplerenone—CYP3A5—cortex of kidney—focal segmental glomerulosclerosis	0.000549	0.0398	CbGeAlD
Eplerenone—Bronchitis—Cyclosporine—focal segmental glomerulosclerosis	0.000543	0.00771	CcSEcCtD
Eplerenone—Upper respiratory tract infection—Cyclosporine—focal segmental glomerulosclerosis	0.000524	0.00745	CcSEcCtD
Eplerenone—NR3C2—ACE Inhibitor Pathway—AGT—focal segmental glomerulosclerosis	0.000522	0.0805	CbGpPWpGaD
Eplerenone—Hyperglycaemia—Cyclosporine—focal segmental glomerulosclerosis	0.000509	0.00723	CcSEcCtD
Eplerenone—Pneumonia—Cyclosporine—focal segmental glomerulosclerosis	0.000506	0.00719	CcSEcCtD
Eplerenone—Infestation—Cyclosporine—focal segmental glomerulosclerosis	0.000503	0.00715	CcSEcCtD
Eplerenone—Infestation NOS—Cyclosporine—focal segmental glomerulosclerosis	0.000503	0.00715	CcSEcCtD
Eplerenone—Depression—Cyclosporine—focal segmental glomerulosclerosis	0.000502	0.00713	CcSEcCtD
Eplerenone—Acute coronary syndrome—Cyclosporine—focal segmental glomerulosclerosis	0.000496	0.00704	CcSEcCtD
Eplerenone—Renal failure—Cyclosporine—focal segmental glomerulosclerosis	0.000494	0.00702	CcSEcCtD
Eplerenone—Myocardial infarction—Cyclosporine—focal segmental glomerulosclerosis	0.000493	0.00701	CcSEcCtD
Eplerenone—Neuropathy peripheral—Cyclosporine—focal segmental glomerulosclerosis	0.000493	0.00701	CcSEcCtD
Eplerenone—Urinary tract infection—Cyclosporine—focal segmental glomerulosclerosis	0.000489	0.00695	CcSEcCtD
Eplerenone—Haematuria—Cyclosporine—focal segmental glomerulosclerosis	0.00048	0.00681	CcSEcCtD
Eplerenone—Hepatobiliary disease—Cyclosporine—focal segmental glomerulosclerosis	0.000476	0.00676	CcSEcCtD
Eplerenone—Hypoaesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.000449	0.00638	CcSEcCtD
Eplerenone—Pharyngitis—Cyclosporine—focal segmental glomerulosclerosis	0.000448	0.00637	CcSEcCtD
Eplerenone—Urinary tract disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000446	0.00634	CcSEcCtD
Eplerenone—Connective tissue disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000444	0.0063	CcSEcCtD
Eplerenone—Urethral disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000443	0.00629	CcSEcCtD
Eplerenone—CYP11B2—ACE Inhibitor Pathway—AGT—focal segmental glomerulosclerosis	0.000427	0.0658	CbGpPWpGaD
Eplerenone—CYP3A4—kidney—focal segmental glomerulosclerosis	0.000423	0.0307	CbGeAlD
Eplerenone—Tinnitus—Cyclosporine—focal segmental glomerulosclerosis	0.000421	0.00598	CcSEcCtD
Eplerenone—Flushing—Cyclosporine—focal segmental glomerulosclerosis	0.000419	0.00595	CcSEcCtD
Eplerenone—Angiopathy—Cyclosporine—focal segmental glomerulosclerosis	0.00041	0.00582	CcSEcCtD
Eplerenone—Mediastinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000407	0.00578	CcSEcCtD
Eplerenone—Mental disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000396	0.00562	CcSEcCtD
Eplerenone—Malnutrition—Cyclosporine—focal segmental glomerulosclerosis	0.000393	0.00558	CcSEcCtD
Eplerenone—Flatulence—Cyclosporine—focal segmental glomerulosclerosis	0.000387	0.0055	CcSEcCtD
Eplerenone—Muscle spasms—Cyclosporine—focal segmental glomerulosclerosis	0.000378	0.00537	CcSEcCtD
Eplerenone—Ill-defined disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000365	0.00518	CcSEcCtD
Eplerenone—Anaemia—Cyclosporine—focal segmental glomerulosclerosis	0.000363	0.00516	CcSEcCtD
Eplerenone—Angioedema—Cyclosporine—focal segmental glomerulosclerosis	0.000359	0.0051	CcSEcCtD
Eplerenone—Malaise—Cyclosporine—focal segmental glomerulosclerosis	0.000354	0.00504	CcSEcCtD
Eplerenone—Cough—Cyclosporine—focal segmental glomerulosclerosis	0.000343	0.00487	CcSEcCtD
Eplerenone—Arthralgia—Cyclosporine—focal segmental glomerulosclerosis	0.000335	0.00475	CcSEcCtD
Eplerenone—Chest pain—Cyclosporine—focal segmental glomerulosclerosis	0.000335	0.00475	CcSEcCtD
Eplerenone—Myalgia—Cyclosporine—focal segmental glomerulosclerosis	0.000335	0.00475	CcSEcCtD
Eplerenone—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—focal segmental glomerulosclerosis	0.000332	0.00472	CcSEcCtD
Eplerenone—Discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.000331	0.0047	CcSEcCtD
Eplerenone—Infection—Cyclosporine—focal segmental glomerulosclerosis	0.000319	0.00453	CcSEcCtD
Eplerenone—Nervous system disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000315	0.00447	CcSEcCtD
Eplerenone—Skin disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000312	0.00443	CcSEcCtD
Eplerenone—Hyperhidrosis—Cyclosporine—focal segmental glomerulosclerosis	0.00031	0.00441	CcSEcCtD
Eplerenone—Musculoskeletal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.000292	0.00415	CcSEcCtD
Eplerenone—Insomnia—Cyclosporine—focal segmental glomerulosclerosis	0.00029	0.00412	CcSEcCtD
Eplerenone—Dyspnoea—Cyclosporine—focal segmental glomerulosclerosis	0.000286	0.00406	CcSEcCtD
Eplerenone—Dyspepsia—Cyclosporine—focal segmental glomerulosclerosis	0.000282	0.00401	CcSEcCtD
Eplerenone—Gastrointestinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000277	0.00393	CcSEcCtD
Eplerenone—Fatigue—Cyclosporine—focal segmental glomerulosclerosis	0.000277	0.00393	CcSEcCtD
Eplerenone—Constipation—Cyclosporine—focal segmental glomerulosclerosis	0.000274	0.0039	CcSEcCtD
Eplerenone—Pain—Cyclosporine—focal segmental glomerulosclerosis	0.000274	0.0039	CcSEcCtD
Eplerenone—Feeling abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.000264	0.00376	CcSEcCtD
Eplerenone—Gastrointestinal pain—Cyclosporine—focal segmental glomerulosclerosis	0.000262	0.00373	CcSEcCtD
Eplerenone—Body temperature increased—Cyclosporine—focal segmental glomerulosclerosis	0.000254	0.0036	CcSEcCtD
Eplerenone—Abdominal pain—Cyclosporine—focal segmental glomerulosclerosis	0.000254	0.0036	CcSEcCtD
Eplerenone—NR3C2—ACE Inhibitor Pathway—TGFB1—focal segmental glomerulosclerosis	0.000253	0.0391	CbGpPWpGaD
Eplerenone—Asthenia—Cyclosporine—focal segmental glomerulosclerosis	0.00023	0.00327	CcSEcCtD
Eplerenone—Pruritus—Cyclosporine—focal segmental glomerulosclerosis	0.000227	0.00322	CcSEcCtD
Eplerenone—Diarrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.000219	0.00312	CcSEcCtD
Eplerenone—Dizziness—Cyclosporine—focal segmental glomerulosclerosis	0.000212	0.00301	CcSEcCtD
Eplerenone—CYP11B2—ACE Inhibitor Pathway—TGFB1—focal segmental glomerulosclerosis	0.000207	0.0319	CbGpPWpGaD
Eplerenone—Vomiting—Cyclosporine—focal segmental glomerulosclerosis	0.000204	0.0029	CcSEcCtD
Eplerenone—Rash—Cyclosporine—focal segmental glomerulosclerosis	0.000202	0.00287	CcSEcCtD
Eplerenone—Dermatitis—Cyclosporine—focal segmental glomerulosclerosis	0.000202	0.00287	CcSEcCtD
Eplerenone—Headache—Cyclosporine—focal segmental glomerulosclerosis	0.000201	0.00286	CcSEcCtD
Eplerenone—Nausea—Cyclosporine—focal segmental glomerulosclerosis	0.000191	0.00271	CcSEcCtD
Eplerenone—NR3C2—Generic Transcription Pathway—CTGF—focal segmental glomerulosclerosis	6.31e-05	0.00973	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	4.93e-05	0.0076	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	4.34e-05	0.00669	CbGpPWpGaD
Eplerenone—NR3C2—Gene Expression—CTGF—focal segmental glomerulosclerosis	3.04e-05	0.00469	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	3.01e-05	0.00464	CbGpPWpGaD
Eplerenone—NR3C2—Generic Transcription Pathway—SERPINE1—focal segmental glomerulosclerosis	2.88e-05	0.00444	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	2.57e-05	0.00397	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—LIPC—focal segmental glomerulosclerosis	2.19e-05	0.00338	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	1.97e-05	0.00304	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—CTGF—focal segmental glomerulosclerosis	1.93e-05	0.00298	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—GNAQ—focal segmental glomerulosclerosis	1.78e-05	0.00275	CbGpPWpGaD
Eplerenone—NR3C2—Gene Expression—SERPINE1—focal segmental glomerulosclerosis	1.39e-05	0.00214	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—LPL—focal segmental glomerulosclerosis	1.34e-05	0.00207	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—AGT—focal segmental glomerulosclerosis	1.15e-05	0.00177	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—LIPC—focal segmental glomerulosclerosis	9.31e-06	0.00144	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—ALB—focal segmental glomerulosclerosis	8.79e-06	0.00136	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—CTGF—focal segmental glomerulosclerosis	8.19e-06	0.00126	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—GNAQ—focal segmental glomerulosclerosis	7.55e-06	0.00116	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—LIPC—focal segmental glomerulosclerosis	6.73e-06	0.00104	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—CTGF—focal segmental glomerulosclerosis	5.92e-06	0.000913	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—LPL—focal segmental glomerulosclerosis	5.68e-06	0.000876	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—GNAQ—focal segmental glomerulosclerosis	5.46e-06	0.000841	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—AGT—focal segmental glomerulosclerosis	4.86e-06	0.000749	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—LPL—focal segmental glomerulosclerosis	4.11e-06	0.000633	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—ALB—focal segmental glomerulosclerosis	3.73e-06	0.000575	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—AGT—focal segmental glomerulosclerosis	3.51e-06	0.000542	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—LIPC—focal segmental glomerulosclerosis	3.13e-06	0.000482	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—CTGF—focal segmental glomerulosclerosis	2.75e-06	0.000425	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—ALB—focal segmental glomerulosclerosis	2.69e-06	0.000416	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—GNAQ—focal segmental glomerulosclerosis	2.54e-06	0.000391	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—LPL—focal segmental glomerulosclerosis	1.91e-06	0.000294	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—AGT—focal segmental glomerulosclerosis	1.63e-06	0.000252	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—ALB—focal segmental glomerulosclerosis	1.25e-06	0.000193	CbGpPWpGaD
